# AZD5672 Bioavailability Study in Healthy Male and Female Subjects

> **NCT00871767** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 24 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** AZD5672
- **DRUG:** AZD5672
- **DRUG:** AZD5672
- **DRUG:** AZD5672

## Key facts

- **NCT ID:** NCT00871767
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** —
- **Final completion:** 2009-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2009-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00871767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00871767, "AZD5672 Bioavailability Study in Healthy Male and Female Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00871767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*